Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced preliminary fourth quarter and full year 2025 net product revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback